| Sporadic and Lynch syndrome-associated mismatch repair-deficient brain tumors H Kim, KY Lim, JW Park, J Kang, JK Won, K Lee, Y Shim, CK Park, ... Laboratory Investigation 102 (2), 160-171, 2022 | 25 | 2022 |
| Molecular subtyping of ependymoma and prognostic impact of Ki-67 KY Lim, K Lee, Y Shim, JW Park, H Kim, J Kang, JK Won, SK Kim, JH Phi, ... Brain Tumor Pathology 39, 1-13, 2022 | 16 | 2022 |
| ZFTA‐YAP1 fusion‐positive ependymoma can occur in the spinal cord KY Lim, KH Lee, JH Phi, H Yun, JK Won, SH Choi, SH Park Brain Pathology 32 (1), e13020, 2022 | 10 | 2022 |
| Revisiting vimentin: a negative surrogate marker of molecularly defined oligodendroglioma in adult type diffuse glioma SI Kim, K Lee, J Bae, S Lee, H Yun, CK Park, SH Choi, CA Maquiling, ... Brain Tumor Pathology 38 (4), 271-282, 2021 | 5 | 2021 |
| Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis K Lee, SI Kim, EE Kim, YM Shim, JK Won, CK Park, SH Choi, H Yun, ... Scientific Reports 13 (1), 6761, 2023 | 3 | 2023 |
| MYB/MYBL1::QKI fusion-positive diffuse glioma YY Suh, K Lee, YM Shim, JH Phi, CK Park, SK Kim, SH Choi, H Yun, ... Journal of Neuropathology & Experimental Neurology 82 (3), 250-260, 2023 | 3 | 2023 |
| Epigenetic alteration of H3K27me3 as a possible oncogenic mechanism of central neurocytoma H Kim, K Lee, YM Shim, EE Kim, SK Kim, JH Phi, CK Park, SH Choi, ... Laboratory Investigation 103 (8), 100159, 2023 | 1 | 2023 |
